Please Wait
Applying Filters...
menu
    • menu
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Naloxone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,350Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    12/09/2024 Rusan Pharma
    India
    		 M/s. Rusan Pharma Limited WC-0278 Naloxone HCl EP/BP/USP 2021-08-27 2024-06-10 Plot No. 6406, GIDC Estate, Ankleshwar-393002, Dist. Bharuch, Gujarat
    03/02/2021 Sun Pharmaceutical Industries Limited
    India
    		 M/s. Sun Pharmaceuticals Ltd. WC-0168 Naloxone Hydrochloride IP/USP, Naloxone Hydrochloride Dihydride EP 2019-07-15 2022-07-14 Plot No.24/2 & 25, Phase-IV, GIDC, Industrial Zone, Panoli-394 116, Dist-Bharuch